SIOX — Sio Gene Therapies Share News
0.000.00%
Last trade - 00:00Brief: Sio Gene Therapies Says On-Track To Report Topline Results From Low-Dose Cohort By End Of 2020
Brief: Axovant Gene Therapies Announces Name Change To Sio Gene Therapies
Brief: Axovant Gene Therapies Announces FDA Clearance Of IND For AXO-AAV-GM2 Gene Therapy In Tay-Sachs And Sandhoff Diseases
U.S. RESEARCH ROUNDUP- Alphabet, Boeing, Lemonade
U.S. STOCKS ON THE MOVE-BioLine RX, Pitney Bowes, Atea Pharma
U.S. STOCKS ON THE MOVE-BioLine RX Ltd, Bellicum Pharma, MoneyGram
U.S. STOCKS ON THE MOVE-BioLine RX, Bellicum Pharma, Mohawk Industries
U.S. STOCKS ON THE MOVE-BioLine RX, Axovant, Bellicum Pharma
Axovant: Slumps on delay in study of gene therapy for Parkinson's
Brief: Axovant To Present AXO-Lenti-PD Program Update On October 30, 2020
Axovant rises after FDA grants rare pediatric disease tag to gene therapy
Brief: Axovant Gene Therapies Receives Rare Pediatric Disease Designation For AXO-AAV-GM2 For Tay-Sachs And Sandhoff Disease
U.S. STOCKS ON THE MOVE-GE, eBay, Eli Lilly, Mallinckrodt, gold miners
U.S. STOCKS ON THE MOVE-Mallinckrodt, Ebay, VivoPower International, Just Energy, Xilinx
U.S. STOCKS ON THE MOVE-GE, Mallinckrodt, Just Energy, cannabis stocks, VivoPower International
Axovant: Rises on FDA's rare pediatric disease status for gene therapy
Brief: Axovant Gene Therapies Receives Rare Pediatric Disease Designation For Axo-Aav-Gm1 For Gm1 Gangliosidosis
Axovant: Slumps after posting gene therapy data from Parkinson's study
U.S. STOCKS ON THE MOVE-Facebook, Amazon.com, Nvidia